Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: Low-Molecular-Weight Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia
By
Yale Cancer Center
FEATURING
Layla Van Doren
By
Yale Cancer Center
FEATURING
Layla Van Doren
Login to view comments.
Click here to Login